NCT03268252View on ClinicalTrials.gov

Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in PNG

CompletedOBSERVATIONAL

Enrollment

3,200

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Lymphatic Filariasis

Trial Locations (1)

Unknown

Papua New Guinean Institute for Medical Research, Maprik

All Listed Sponsors

collaborator

Papua New Guinea Institute of Medical Research

OTHER_GOV

lead

University Hospitals Cleveland Medical Center

OTHER

NCT03268252 - Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in PNG | Biotech Hunter | Biotech Hunter